Recent studies have reported that COVID-19 patients are mostly in a high systemic inflammatory condition with excessive cytokine releases which is characterized by high levels of interleukin-6 (IL-6), IL-8, and tumor necrosis factor-α (TNF-α) that contribute to deadly complications (5, 6). This evidence concerns the gene IL6 and COVID-19.